Analysis reveals the signature of the antiviral drug molnupiravir in SARS-CoV-2 sequences riddled with mutations. By Ewen Callaway A drug widely used to treat COVID-19 might be spurring the evolution of new SARS-CoV-2 variants. The drug, molnupiravir, works by...
COVID drug drives viral mutations — and now some want to halt its use
read more